Versigent director sells 122,722 shares in 10b5-1 plan
A Versigent PLC director disclosed selling 122,722 ordinary shares over two days under a pre-arranged Rule 10b5-1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Versigent PLC (VGNT) director Kevin P. Clark reported open-market sales of a total of 122,722 Ordinary Shares on September 8–9, 2026, in multiple tranches at weighted average prices between $44.99 and $50.12 per share, as detailed by price ranges in the footnotes.
The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Clark on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. The filing does not state Clark’s share holdings after these sales.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F5 | 57,508 | $45.49 | $2.62M |
| Sale | Ordinary Shares F1, F6 | 16,517 | $46.27 | $764K |
| Sale | Ordinary Shares F1, F7 | 105 | $47.08 | $5K |
| Sale | Ordinary Shares F1, F2 | 38,271 | $47.85 | $1.83M |
| Sale | Ordinary Shares F1, F3 | 9,034 | $48.50 | $438K |
| Sale | Ordinary Shares F1, F4 | 1,287 | $49.67 | $64K |
Footnotes (7)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.30 to $48.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.30 to $49.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.40 to $50.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.99 to $45.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.99 to $46.93, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F7. All shares were sold at $47.08.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Revocable Trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did VGNT director Kevin P. Clark report?
AI-generated analysis. How Rhea-AI works. Not financial advice.